Answers are grounded in this paper and cite their sources.
Methodology for preparing dipeptide analogues in which a carbon-carbon double bond replaces the normal amide bond is described. Thus, the protected tyrosylglycine analogue, (S)-trans-5-t-butyloxycarbonylamino-6-(4-tbutoxyphenyl)hex-3-enoic acid has been synthesised and incorporated into the Leu-enkephalin analogue (3) by condensation with glycylphenylalanyl-leucine. The enkephalin analogue retained biological activity. The significance of this isosteric replacement of the amide group is discussed.
No takes yet. Share an insight, caveat, or question.
Hann et al. (1982) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: